Skip to main content
Clinical Trials/NL-OMON22078
NL-OMON22078
Not yet recruiting
Not Applicable

An integrated optimization of surgery and radiotherapy techniques to improve cosmetic outcome and quality of life in breast conserving therapy for breast cancer patients

Erasmus MC0 sites750 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Erasmus MC
Enrollment
750
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Sponsor
Erasmus MC

Eligibility Criteria

Inclusion Criteria

  • Female patients aged \= 18 years
  • History of BCT with adjuvant radiation therapy for non\-metastatic, histologically proven invasive breast cancer (pT1\-3N0\-2a) or DCIS. In light of BCT adjuvant systemic treatment (i.e. endocrine therapy, chemotherapy and immune therapy) is allowed.
  • Breast conserving surgery between 1st of January 2016 and 31th of December 2018
  • Treated according to the currently applied dose fractionation schedules, i.e. whole breast radiotherapy, with or without boost
  • Adequate understanding of the Dutch language and written informed consent

Exclusion Criteria

  • Any breast surgery or re\-irradiation on the breast area after BCT
  • Progression of disease (and additional treatment) since BCT
  • Patients who received partial breast irradiation
  • Current pregnancy or breast feeding

Outcomes

Primary Outcomes

Not specified

Similar Trials